237 related articles for article (PubMed ID: 32501183)
1. Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature.
Jackson LD; Wortzman R; Chua D; Selby D
J Oncol Pharm Pract; 2021 Jan; 27(1):238-243. PubMed ID: 32501183
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
Clemens KE; Klaschik E
Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
[TBL] [Abstract][Full Text] [Related]
3. The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients.
Reddy A; Tayjasanant S; Haider A; Heung Y; Wu J; Liu D; Yennurajalingam S; Reddy S; de la Cruz M; Rodriguez EM; Waletich J; Vidal M; Arthur J; Holmes C; Tallie K; Wong A; Dev R; Williams J; Bruera E
Cancer; 2016 Jan; 122(1):149-56. PubMed ID: 26451687
[TBL] [Abstract][Full Text] [Related]
4. The Opioid Rotation Ratio From Transdermal Fentanyl to "Strong" Opioids in Patients With Cancer Pain.
Reddy A; Yennurajalingam S; Reddy S; Wu J; Liu D; Dev R; Bruera E
J Pain Symptom Manage; 2016 Jun; 51(6):1040-5. PubMed ID: 26826675
[TBL] [Abstract][Full Text] [Related]
5. Transdermal fentanyl in cachectic cancer patients.
Heiskanen T; Mätzke S; Haakana S; Gergov M; Vuori E; Kalso E
Pain; 2009 Jul; 144(1-2):218-22. PubMed ID: 19442446
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
7. Pediatric palliative care: use of opioids for the management of pain.
Zernikow B; Michel E; Craig F; Anderson BJ
Paediatr Drugs; 2009; 11(2):129-51. PubMed ID: 19301934
[TBL] [Abstract][Full Text] [Related]
8. Transdermal fentanyl to parenteral morphine route switch and drug rotation in refractory cancer cachexia.
Alsirafy SA; Alabdullateef SH; Elyamany AM; Hassan AD; Almashiakhi M
BMJ Support Palliat Care; 2022 Jul; 12(e2):e184-e186. PubMed ID: 31492673
[TBL] [Abstract][Full Text] [Related]
9. Dose conversion in opioid rotation from continuous intravenous infusion of morphine hydrochloride injection to fentanyl patch in the management of cancer pain.
Kawano C; Hirayama T; Kuroyama M
Yakugaku Zasshi; 2011 Mar; 131(3):463-7. PubMed ID: 21372544
[TBL] [Abstract][Full Text] [Related]
10. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
[TBL] [Abstract][Full Text] [Related]
12. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Juba KM; Wahler RG; Daron SM
J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
[TBL] [Abstract][Full Text] [Related]
13. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
14. Cancer Cachexia May Hinder Pain Control When Using Fentanyl Patch.
Chiba T; Takahashi H; Tairabune T; Kimura S; Ueda H; Kudo K
Biol Pharm Bull; 2020; 43(5):873-878. PubMed ID: 32378563
[TBL] [Abstract][Full Text] [Related]
15. Opioid Rotation in Cancer Pain Treatment.
Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
[TBL] [Abstract][Full Text] [Related]
16. Resolution of Intrathecal Hydromorphone or Morphine-induced Peripheral Edema by Opioid Rotation to Fentanyl: A Case Series.
Veizi E; Tornero-Bold M; Hayek SM
Pain Pract; 2016 Jul; 16(6):E94-8. PubMed ID: 26990069
[TBL] [Abstract][Full Text] [Related]
17. Opioid rotation in the treatment of joint pain. A review of 67 cases.
Grilo RM; Bertin P; Scotto di Fazano C; Coyral D; Bonnet C; Vergne P; Treves R
Joint Bone Spine; 2002 Oct; 69(5):491-4. PubMed ID: 12477234
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
Botterman J; Criel N
Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
[TBL] [Abstract][Full Text] [Related]
19. [A study of transdermal fentanyl in cancer pain at Aichi-Cancer Center].
Kato K; Mizaki T; Yamazaki S; Nitta M; Hasegawa M; Kamiya Y; Hosoda R
Yakugaku Zasshi; 2004 May; 124(5):287-91. PubMed ID: 15118241
[TBL] [Abstract][Full Text] [Related]
20. Opioid Rotation and Conversion Ratios Used by Palliative Care Professionals: An International Survey.
Reddy A; Sinclair C; Crawford GB; McPherson ML; Mercadante S; Hui D; Haider A; Arthur J; Tanco K; Dalal S; Dev R; Amaram-Davila J; Adile C; Liu D; Schuler U; Jammi S; Shelal Z; Del Fabbro E; Davis M; Bruera E
J Palliat Med; 2022 Oct; 25(10):1557-1562. PubMed ID: 35930252
[No Abstract] [Full Text] [Related]
[Next] [New Search]